SCHEMBL3670907

SCHEMBL3670907

CC(C)(C)OC(=O)N1CCCCC1NC(=O)c1ccc(Cn2cccn2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 2/20 0.50
HDAC6 Q9UBN7 2/20 0.50
HRH3 Q9Y5N1 3/20 0.46
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
MAPT P10636 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
LMNA P02545 1/20 0.41
HPGD P15428 1/20 0.41
KLKB1 P03952 1/20 0.41
SRC P12931 1/20 0.40
NPC1 O15118 2/20 0.40
GAA P10253 2/20 0.40
KDM4E B2RXH2 2/20 0.40
RAB9A P51151 1/20 0.40
GPR119 Q8TDV5 1/20 0.39
HTT P42858 2/20 0.39
NPSR1 Q6W5P4 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
MMP7 P09237 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4942925 0.83 HDAC4 (0.52) HDAC1HDAC6MEN1KMT2AMAPT
SCHEMBL4946817 0.82 USP30 (0.57) HDAC1HDAC6HRH3
SCHEMBL3674391 0.81 HDAC6 (0.54) HDAC1HDAC6HRH3GPR119
SCHEMBL4943304 0.81 HDAC6 (0.54) HDAC1HDAC6HRH3GPR119
SCHEMBL28961482 0.76 USP30 (0.54) MEN1KMT2ALMNANPC1KDM4E
SCHEMBL4943963 0.73 HRH3 (0.64) HRH3GPR119
SCHEMBL30509621 0.72 KDM4E (0.52) KMT2ANPC1GAAKDM4ERAB9A
SCHEMBL3725304 0.72 ALDH1A1 (0.52) HRH3MAPTNPC1RAB9AGPR119
SCHEMBL3725305 0.72 ALDH1A1 (0.52) HRH3MAPTNPC1RAB9AGPR119
SCHEMBL4942926 0.72 HRH3 (0.67) HRH3GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2155719-A1 AZACYCLYLBENZAMIDE DERIVATIVES AS HISTAMINE-3 ANTAGONISTS Wyeth LLC (US) 2010-02-24 EP disclosed
WO-2008147945-A1 AZACYCLYLBENZAMIDE DERIVATIVES AS HISTAMINE-3 ANTAGONISTS WYETH (US) 2008-12-04 WO disclosed